Cargando…

Haemophagocytic syndrome and COVID-19

Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic hyperinflammatory syndromes with a common terminal pathway triggered by different etiopathogenetic factors. HLH is characterised by a decreased capacity of interferon gamma production with an activated NK phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Retamozo, Soledad, Brito-Zerón, Pilar, Sisó-Almirall, Antoni, Flores-Chávez, Alejandra, Soto-Cárdenas, María-José, Ramos-Casals, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778844/
https://www.ncbi.nlm.nih.gov/pubmed/33389315
http://dx.doi.org/10.1007/s10067-020-05569-4
_version_ 1783631208049016832
author Retamozo, Soledad
Brito-Zerón, Pilar
Sisó-Almirall, Antoni
Flores-Chávez, Alejandra
Soto-Cárdenas, María-José
Ramos-Casals, Manuel
author_facet Retamozo, Soledad
Brito-Zerón, Pilar
Sisó-Almirall, Antoni
Flores-Chávez, Alejandra
Soto-Cárdenas, María-José
Ramos-Casals, Manuel
author_sort Retamozo, Soledad
collection PubMed
description Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic hyperinflammatory syndromes with a common terminal pathway triggered by different etiopathogenetic factors. HLH is characterised by a decreased capacity of interferon gamma production with an activated NK phenotype profile similar to other hyperinflammatory syndromes. Viruses are closely linked to the development of HLH as infectious triggers, and the break of tolerance to self-antigens is considered a critical mechanism involved in the development of immune-mediated conditions triggered by viral infections. Emerging studies in patients with COVID-19 are suggesting a key role of monocytes/macrophages in the pathogenesis of this viral infection, and there is a significant overlap between several features reported in severe COVID-19 and the features included in the HLH-2004 diagnostic criteria. Therefore, SARS-Cov-2, as other respiratory viruses, may also be considered a potential etiological trigger of HLH. The frequency of HLH in adult patients with severe COVID-19 is lower than 5%, although this figure could be underestimated considering that most reported cases lacked information about some specific criteria (mainly the histopathological criteria and the measurement of NK cell function and sCD25 levels). Because HLH is a multi-organ syndrome, the diagnostic approach in a patient with severe COVID-19 in whom HLH is suspected must be carried out in a syndromic and holistic way, and not in the light of isolated clinical or laboratory features. In COVID-19 patients presenting with persistent high fever, progressive pancytopenia, and hepatosplenic involvement, together with the characteristic triad of laboratory abnormalities (hyperferritinaemia, hypertriglyceridaemia, and hypofibrinogenaemia), the suspicion of HLH is high, and the diagnostic workup must be completed with specific immunological and histopathological studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10067-020-05569-4.
format Online
Article
Text
id pubmed-7778844
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-77788442021-01-04 Haemophagocytic syndrome and COVID-19 Retamozo, Soledad Brito-Zerón, Pilar Sisó-Almirall, Antoni Flores-Chávez, Alejandra Soto-Cárdenas, María-José Ramos-Casals, Manuel Clin Rheumatol Review Article Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic hyperinflammatory syndromes with a common terminal pathway triggered by different etiopathogenetic factors. HLH is characterised by a decreased capacity of interferon gamma production with an activated NK phenotype profile similar to other hyperinflammatory syndromes. Viruses are closely linked to the development of HLH as infectious triggers, and the break of tolerance to self-antigens is considered a critical mechanism involved in the development of immune-mediated conditions triggered by viral infections. Emerging studies in patients with COVID-19 are suggesting a key role of monocytes/macrophages in the pathogenesis of this viral infection, and there is a significant overlap between several features reported in severe COVID-19 and the features included in the HLH-2004 diagnostic criteria. Therefore, SARS-Cov-2, as other respiratory viruses, may also be considered a potential etiological trigger of HLH. The frequency of HLH in adult patients with severe COVID-19 is lower than 5%, although this figure could be underestimated considering that most reported cases lacked information about some specific criteria (mainly the histopathological criteria and the measurement of NK cell function and sCD25 levels). Because HLH is a multi-organ syndrome, the diagnostic approach in a patient with severe COVID-19 in whom HLH is suspected must be carried out in a syndromic and holistic way, and not in the light of isolated clinical or laboratory features. In COVID-19 patients presenting with persistent high fever, progressive pancytopenia, and hepatosplenic involvement, together with the characteristic triad of laboratory abnormalities (hyperferritinaemia, hypertriglyceridaemia, and hypofibrinogenaemia), the suspicion of HLH is high, and the diagnostic workup must be completed with specific immunological and histopathological studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10067-020-05569-4. Springer International Publishing 2021-01-03 2021 /pmc/articles/PMC7778844/ /pubmed/33389315 http://dx.doi.org/10.1007/s10067-020-05569-4 Text en © International League of Associations for Rheumatology (ILAR) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Retamozo, Soledad
Brito-Zerón, Pilar
Sisó-Almirall, Antoni
Flores-Chávez, Alejandra
Soto-Cárdenas, María-José
Ramos-Casals, Manuel
Haemophagocytic syndrome and COVID-19
title Haemophagocytic syndrome and COVID-19
title_full Haemophagocytic syndrome and COVID-19
title_fullStr Haemophagocytic syndrome and COVID-19
title_full_unstemmed Haemophagocytic syndrome and COVID-19
title_short Haemophagocytic syndrome and COVID-19
title_sort haemophagocytic syndrome and covid-19
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778844/
https://www.ncbi.nlm.nih.gov/pubmed/33389315
http://dx.doi.org/10.1007/s10067-020-05569-4
work_keys_str_mv AT retamozosoledad haemophagocyticsyndromeandcovid19
AT britozeronpilar haemophagocyticsyndromeandcovid19
AT sisoalmirallantoni haemophagocyticsyndromeandcovid19
AT floreschavezalejandra haemophagocyticsyndromeandcovid19
AT sotocardenasmariajose haemophagocyticsyndromeandcovid19
AT ramoscasalsmanuel haemophagocyticsyndromeandcovid19